CABOMETYX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Apr 2023)
What this means for you
Registered since 20 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86621339
- Registration number
- 5105828
- Mark type
- Stylized text
- Filed
- 06 May 2015
- Published for opposition
- 22 Sept 2015
- Registered
- 20 Dec 2016
- Attorney of record
- Anessa Owen Kramer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, pain, infection, inflammation, hormone disorders, bone disorders, and mental disorders; analgesics; hormones; psychotropics; anti-infectives; anti-inflammatories; anti-cancer preparations
Owner
- Exelixis, Inc., Alameda, CA, US
- Exelixis, Inc., South San Francisco, CA, US
- Exelixis, Inc., South San Francisco, CA, US
Prosecution history
- 20 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Apr 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Apr 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 15 Nov 2022 — OFFICE ACTION ISSUED POU1
- 14 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Oct 2022 — TEAS SECTION 8 & 15 RECEIVED
- 20 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Dec 2016 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Nov 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Nov 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Nov 2016 — USE AMENDMENT FILED
- 01 Nov 2016 — TEAS STATEMENT OF USE RECEIVED
- 31 Aug 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED